Leading scientists have called for Europe to invest more funds in the study of lipids that play a crucial role in the function of human cells and which are implicated in a range of diseases including obesity, diabetes and Alzheimer’s disease.
A report published recently by the European Science Foundation (ESF) urges greater cooperation among researchers and more investment in the field of lipidomics – the term given to the identification and analysis of the full complement of lipids in cells, tissues and body fluids, together with associated molecular structures such as enzymes and genes. The document is the output of a science policy activity led by the European Medical Research Councils (EMRC), the medical section within ESF.
www.esf.org